These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 25591514

  • 21. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A, Valldeoriola F, Linazasoro G, Rodriguez-Oroz MC, Stochi F, Marin C, Rodriguez M, Vaamonde J, Jenner P, Alvarez L, Pavon N, Macias R, Luquin MR, Hernandez B, Grandas F, Gimenez-Roldan S, Tolosa E, Obeso JA.
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [Abstract] [Full Text] [Related]

  • 22. Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
    Silver DE.
    Expert Rev Neurother; 2004 Jul; 4(4):589-99. PubMed ID: 15853578
    [Abstract] [Full Text] [Related]

  • 23. Should levodopa dose be reduced when switched to stalevo?
    Linazasoro G, Kulisevsky J, Hernández B, Spanish Stalevo Study Group.
    Eur J Neurol; 2008 Mar; 15(3):257-61. PubMed ID: 18215153
    [Abstract] [Full Text] [Related]

  • 24. Levodopa/carbidopa/entacapone (Stalevo).
    Hauser RA.
    Neurology; 2004 Jan 13; 62(1 Suppl 1):S64-71. PubMed ID: 14718682
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Levodopa/carbidopa/entacapone in Parkinson's disease.
    Seeberger LC, Hauser RA.
    Expert Rev Neurother; 2009 Jul 13; 9(7):929-40. PubMed ID: 19589043
    [Abstract] [Full Text] [Related]

  • 34. Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia.
    Sampaio C, Ferreira JJ.
    Nat Rev Neurol; 2010 Nov 13; 6(11):590-1. PubMed ID: 21048799
    [No Abstract] [Full Text] [Related]

  • 35. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE.
    Mayo Clin Proc; 2014 Jul 13; 89(7):997-1003. PubMed ID: 24996235
    [Abstract] [Full Text] [Related]

  • 36. Clinical inquiry. Which drugs work best for early Parkinson's disease?
    Jain L, Benko R, Safranek S.
    J Fam Pract; 2012 Feb 13; 61(2):106-8. PubMed ID: 22312616
    [Abstract] [Full Text] [Related]

  • 37. Levodopa-Carbidopa-Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience.
    Szász JA, Dulamea AO, Constantin VA, Mureşanu DF, Dumbravă LP, Tiu C, Jianu DC, Simu M, Ene A, Axelerad A, Falup-Pecurariu C, Lungu M, Danci AG, Sabau M, Strilciuc Ş, Popescu BO.
    Am J Ther; 2012 Feb 13; 31(3):e209-e218. PubMed ID: 38460175
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.
    Zangaglia R, Stocchi F, Sciarretta M, Antonini A, Mancini F, Guidi M, Martignoni E, Pacchetti C.
    Clin Neuropharmacol; 2010 Feb 13; 33(2):61-6. PubMed ID: 19935405
    [Abstract] [Full Text] [Related]

  • 40. [The optimization of using levodopa in patients with Parkinson's disease: results of the OPTIMA study].
    Datieva VK, Makotrova TA, Levin OS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Feb 13; 112(10 Pt 2):13-9. PubMed ID: 23250605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.